Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review
Autor(a) principal: | |
---|---|
Data de Publicação: | 2016 |
Outros Autores: | , , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Microbiology |
Texto Completo: | http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822016000400793 |
Resumo: | Abstract Triazole fungicides are used broadly for the control of infectious diseases of both humans and plants. The surge in resistance to triazoles among pathogenic populations is an emergent issue both in agriculture and medicine. The non-rational use of fungicides with site-specific modes of action, such as the triazoles, may increase the risk of antifungal resistance development. In the medical field, the surge of resistant fungal isolates has been related to the intensive and recurrent therapeutic use of a limited number of triazoles for the treatment and prophylaxis of many mycoses. Similarities in the mode of action of triazole fungicides used in these two fields may lead to cross-resistance, thus expanding the spectrum of resistance to multiple fungicides and contributing to the perpetuation of resistant strains in the environment. The emergence of fungicide-resistant isolates of human pathogens has been related to the exposure to fungicides used in agroecosystems. Examples include species of cosmopolitan occurrence, such as Fusarium and Aspergillus, which cause diseases in both plants and humans. This review summarizes the information about the most important triazole fungicides that are largely used in human clinical therapy and agriculture. We aim to discuss the issues related to fungicide resistance and the recommended strategies for preventing the emergence of triazole-resistant fungal populations capable of spreading across environments. |
id |
SBM-1_0672355649688beb57294a916a32e7a8 |
---|---|
oai_identifier_str |
oai:scielo:S1517-83822016000400793 |
network_acronym_str |
SBM-1 |
network_name_str |
Brazilian Journal of Microbiology |
repository_id_str |
|
spelling |
Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini reviewCross-resistanceEmerging fungal pathogensFungicide sensitivityAgricultureMedicineAbstract Triazole fungicides are used broadly for the control of infectious diseases of both humans and plants. The surge in resistance to triazoles among pathogenic populations is an emergent issue both in agriculture and medicine. The non-rational use of fungicides with site-specific modes of action, such as the triazoles, may increase the risk of antifungal resistance development. In the medical field, the surge of resistant fungal isolates has been related to the intensive and recurrent therapeutic use of a limited number of triazoles for the treatment and prophylaxis of many mycoses. Similarities in the mode of action of triazole fungicides used in these two fields may lead to cross-resistance, thus expanding the spectrum of resistance to multiple fungicides and contributing to the perpetuation of resistant strains in the environment. The emergence of fungicide-resistant isolates of human pathogens has been related to the exposure to fungicides used in agroecosystems. Examples include species of cosmopolitan occurrence, such as Fusarium and Aspergillus, which cause diseases in both plants and humans. This review summarizes the information about the most important triazole fungicides that are largely used in human clinical therapy and agriculture. We aim to discuss the issues related to fungicide resistance and the recommended strategies for preventing the emergence of triazole-resistant fungal populations capable of spreading across environments.Sociedade Brasileira de Microbiologia2016-12-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822016000400793Brazilian Journal of Microbiology v.47 n.4 2016reponame:Brazilian Journal of Microbiologyinstname:Sociedade Brasileira de Microbiologia (SBM)instacron:SBM10.1016/j.bjm.2016.06.006info:eu-repo/semantics/openAccessRibas e Ribas,Aícha DanielaSpolti,PierriDel Ponte,Emerson MedeirosDonato,Katarzyna ZawadaSchrekker,HenriFuentefria,Alexandre Meneghelloeng2016-11-21T00:00:00Zoai:scielo:S1517-83822016000400793Revistahttps://www.scielo.br/j/bjm/ONGhttps://old.scielo.br/oai/scielo-oai.phpbjm@sbmicrobiologia.org.br||mbmartin@usp.br1678-44051517-8382opendoar:2016-11-21T00:00Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM)false |
dc.title.none.fl_str_mv |
Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review |
title |
Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review |
spellingShingle |
Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review Ribas e Ribas,Aícha Daniela Cross-resistance Emerging fungal pathogens Fungicide sensitivity Agriculture Medicine |
title_short |
Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review |
title_full |
Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review |
title_fullStr |
Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review |
title_full_unstemmed |
Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review |
title_sort |
Is the emergence of fungal resistance to medical triazoles related to their use in the agroecosystems? A mini review |
author |
Ribas e Ribas,Aícha Daniela |
author_facet |
Ribas e Ribas,Aícha Daniela Spolti,Pierri Del Ponte,Emerson Medeiros Donato,Katarzyna Zawada Schrekker,Henri Fuentefria,Alexandre Meneghello |
author_role |
author |
author2 |
Spolti,Pierri Del Ponte,Emerson Medeiros Donato,Katarzyna Zawada Schrekker,Henri Fuentefria,Alexandre Meneghello |
author2_role |
author author author author author |
dc.contributor.author.fl_str_mv |
Ribas e Ribas,Aícha Daniela Spolti,Pierri Del Ponte,Emerson Medeiros Donato,Katarzyna Zawada Schrekker,Henri Fuentefria,Alexandre Meneghello |
dc.subject.por.fl_str_mv |
Cross-resistance Emerging fungal pathogens Fungicide sensitivity Agriculture Medicine |
topic |
Cross-resistance Emerging fungal pathogens Fungicide sensitivity Agriculture Medicine |
description |
Abstract Triazole fungicides are used broadly for the control of infectious diseases of both humans and plants. The surge in resistance to triazoles among pathogenic populations is an emergent issue both in agriculture and medicine. The non-rational use of fungicides with site-specific modes of action, such as the triazoles, may increase the risk of antifungal resistance development. In the medical field, the surge of resistant fungal isolates has been related to the intensive and recurrent therapeutic use of a limited number of triazoles for the treatment and prophylaxis of many mycoses. Similarities in the mode of action of triazole fungicides used in these two fields may lead to cross-resistance, thus expanding the spectrum of resistance to multiple fungicides and contributing to the perpetuation of resistant strains in the environment. The emergence of fungicide-resistant isolates of human pathogens has been related to the exposure to fungicides used in agroecosystems. Examples include species of cosmopolitan occurrence, such as Fusarium and Aspergillus, which cause diseases in both plants and humans. This review summarizes the information about the most important triazole fungicides that are largely used in human clinical therapy and agriculture. We aim to discuss the issues related to fungicide resistance and the recommended strategies for preventing the emergence of triazole-resistant fungal populations capable of spreading across environments. |
publishDate |
2016 |
dc.date.none.fl_str_mv |
2016-12-01 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.status.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822016000400793 |
url |
http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1517-83822016000400793 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
10.1016/j.bjm.2016.06.006 |
dc.rights.driver.fl_str_mv |
info:eu-repo/semantics/openAccess |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
text/html |
dc.publisher.none.fl_str_mv |
Sociedade Brasileira de Microbiologia |
publisher.none.fl_str_mv |
Sociedade Brasileira de Microbiologia |
dc.source.none.fl_str_mv |
Brazilian Journal of Microbiology v.47 n.4 2016 reponame:Brazilian Journal of Microbiology instname:Sociedade Brasileira de Microbiologia (SBM) instacron:SBM |
instname_str |
Sociedade Brasileira de Microbiologia (SBM) |
instacron_str |
SBM |
institution |
SBM |
reponame_str |
Brazilian Journal of Microbiology |
collection |
Brazilian Journal of Microbiology |
repository.name.fl_str_mv |
Brazilian Journal of Microbiology - Sociedade Brasileira de Microbiologia (SBM) |
repository.mail.fl_str_mv |
bjm@sbmicrobiologia.org.br||mbmartin@usp.br |
_version_ |
1752122208727072768 |